AMD updated - page 21

21
The 5-year incidence and risk factors for age-related maculopathy
in a general Japanese population: the Hisayama study. Invest Oph-
thalmol Vis Sci 2005; 46 (6): 1907-10.
28. Friedman DS, Katz J, Bressler NM, Rahmani B, Tielsch JM. Racial
differences in the prevalence of age-related macular degeneration:
the Baltimore Eye Survey. Ophthalmology 1999; 106 (6): 1049-55.
29. Klein R, Klein BE, Linton KL. Prevalence of age-related macu-
lopathy. The Beaver Dam Eye Study. Ophthalmology 1992; 99
(6): 933-43.
30. Bressler SB, Muñoz B, Solomon SD, West SK; Salisbury Eye
Evaluation (SEE) Study Team. Racial differences in the prevalence
of age-related macular degeneration: the Salisbury Eye Evaluation
(SEE) Project. Arch Ophthalmol 2008; 126 (2): 241-5.
31. Klein R, Clegg L, Cooper LS, Hubbard LD, Klein BE, King WN, Fol-
som AR. Prevalence of age-related maculopathy in the Atherosclerosis
Risk in Communities Study. Arch Ophthalmol 1999; 117 (9): 1203-10.
32. Klein R, Klein BE, Marino EK, Kuller LH, Furberg C, Burke GL,
Hubbard LD. Early age-related maculopathy in the cardiovascular
health study. Ophthalmology 2003; 110 (1): 25-33.
33. Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related
maculopathy in Australia. The Blue Mountains Eye Study. Oph-
thalmology 1995; 102 (10): 1450-60..
34. VanNewkirk MR, Nanjan MB, Wang JJ, Mitchell P, Taylor HR,
McCarty CA. The prevalence of age-related maculopathy: the vi-
sual impairment project. Ophthalmology 2000; 107 (8): 1593-
600.
35. Vingerling JR, Dielemans I, Hofman A, Grobbee DE, Hijmering
M, Kramer CF, de Jong PT. The prevalence of age-related macu-
lopathy in the Rotterdam Study. Ophthalmology 1995; 102 (2):
205-10.
36. Delcourt C, Diaz JL, Ponton-Sanchez A, Papoz L. Smoking and
age-related macular degeneration. The POLA Study. Pathologies
Oculaires Liées à l’Age. Arch Ophthalmol 1998; 116 (8): 1031-5.
37. Topouzis F, Coleman AL, Harris A, Anastasopoulos E, Yu F,
Koskosas A, Pappas T, Mavroudis L, Wilson MR. Prevalence of
age-related macular degeneration in Greece: the Thessaloniki Eye
Study. Am J Ophthalmol 2006; 142 (6): 1076-9. 5.
38. Krishnaiah S, Das T, Nirmalan PK, Nutheti R, Shamanna BR,
Rao GN, Thomas R. Risk factors for age-related macular degen-
eration: findings from the Andhra Pradesh eye disease study in
South India. Invest Ophthalmol Vis Sci 2005; 46 (12): 4442-9.
Epidemiology of AMD
1...,11,12,13,14,15,16,17,18,19,20 22,23,24,25,26,27,28,29,30,31,...258
Powered by FlippingBook